Literature DB >> 6260662

Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.

H J Zweerink, D Martinez, R J Lynch, L W Stanton.   

Abstract

We performed experiments with mice to determine the nature of the immune response(s) that prevents primary infections of the skin and the trigeminal ganglia with herpes simplex virus. Immunization with infectious herpes simplex virus, inactivated virus, or material enriched for viral glycoproteins protected hairless mice against primary facial and ganglionic infections. Live and inactivated viruses induced neutralizing antibodies, whereas glycoprotein material did not. Instead, glycoprotein material induced antibodies that were largely directed against two glycopolypeptides with molecular weights of 120,000 to 130,000. Hairless mice immunized with glycoprotein material responded faster than control mice in the synthesis of neutralizing antibodies after challenge with infectious virus. Congenital athymic BALB/c (nu/nu) mice were protected against primary facial infections after immunization with glycoprotein material, but glycoprotein-specific antibodies were not induced.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260662      PMCID: PMC351779          DOI: 10.1128/iai.31.1.267-275.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Reactivation of latent Herpes simplex virus after pneumococcal pneumonia in mice.

Authors:  J G Stevens; M L Cook; M C Jordan
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 3.  Infection with herpes-simplex viruses 1 and 2. 1.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  Infectious herpesvirus DNA.

Authors:  F L Graham; G Veldhuisen; N M Wilkie
Journal:  Nat New Biol       Date:  1973-10-31

5.  Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  Nat New Biol       Date:  1971-09-08

6.  A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans.

Authors:  R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

7.  Macrophages and age-dependent resistance to Herpes simplex virus in mice.

Authors:  M S Hirsch; B Zisman; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

8.  Polypeptide components of virions, top component and cores of reovirus type 3.

Authors:  R E Smith; H J Zweerink; W K Joklik
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

9.  A useful quantitative semimicromethod for viral plaque assay.

Authors:  B Rager-Zisman; T C Merigan
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

10.  The association of herpesvirus type 2 and carcinoma of the uterine cervix.

Authors:  W E Rawls; W A Tompkins; J L Melnick
Journal:  Am J Epidemiol       Date:  1969-05       Impact factor: 4.897

View more
  5 in total

1.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

2.  Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.

Authors:  J Glorioso; C H Schröder; G Kumel; M Szczesiul; M Levine
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

3.  Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.

Authors:  H J Zweerink; L Corey
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

5.  Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice.

Authors:  T A Thomson; J Hilfenhaus; H Moser; P S Morahan
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.